G9077
HCPCSOnc dx prostate t1no progres
Official HCPCS Level II long descriptor
Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
HCPCS Level II code G9077 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Onc dx prostate t1no progres
Added to HCPCS: 2006-01-01
Nearby codes in G9
- G9068Onc dx sclc/nsclc limited
- G9069Onc dx sclc/nsclc ext at dx
- G9070Onc dx sclc/nsclc ext unknwn
- G9071Onc dx brst stg1-2b hr,nopro
- G9072Onc dx brst stg1-2 noprogres
- G9073Onc dx brst stg3-hr, no pro
- G9074Onc dx brst stg3-noprogress
- G9075Onc dx brst metastic/ recur
- G9078Onc dx prostate t2no progres
- G9079Onc dx prostate t3b-t4noprog
- G9080Onc dx prostate w/rise psa
- G9083Onc dx prostate unknwn nos
- G9084Onc dx colon t1-3,n1-2,no pr
- G9085Onc dx colon t4, n0 w/o prog
- G9086Onc dx colon t1-4 no dx prog
- G9087Onc dx colon metas evid dx
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.